This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mead Johnson Nutrition Expands Board And Appoints Michael Grobstein As Director

Mead Johnson Nutrition Company (NYSE: MJN) announced today that it is expanding the size of its board from eleven to twelve members and appointing Michael Grobstein as its newest director. He is a retired Vice Chairman of Ernst & Young LLP, one of the world's largest professional services organizations.

Mr. Grobstein, 71, is currently on the board of directors of Bristol-Myers Squibb, where he is a member of the audit committee, as well as the compensation and management development committees. He was also a director of Given Imaging, Ltd., where he served on several committees and was chair of the audit committee, until its recent acquisition by Covidien plc.

Having joined Ernst & Young in 1964, Mr. Grobstein was made a partner in 1975. He served as a Vice Chairman from 1984 until his retirement in 1998. During that period, he held a series of companywide leadership positions that included responsibility for Accounting and Auditing Services; Planning, Marketing and Industry Services; and areas of International Operations.

Mr. Grobstein currently serves on the boards of the Central Park Conservancy and the Peer Health Exchange.

"Mike's knowledge of accounting, internal controls and financial reporting rules and regulations – along with his varied experience serving on the boards of several global companies – will add additional depth and strength to the broad expertise of our current board," commented James M. Cornelius, chairman of the Mead Johnson board.

About Mead Johnson

Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company's mission is to create nutritional brands and products trusted to give infants and children the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company's "Enfa" family of brands, including Enfamil ® infant formula, is the world's leading brand franchise in pediatric nutrition. For more information, go to meadjohnson.com.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs